ArticleJPRAS open2025
Reconstruction of radiation-induced damage in patients with facial hemangiomas using free anterolateral thigh flap.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Radiation therapy to treat hemangiomas is an old method that is no longer used due to its severe side effects. However, in Vietnam, radiotherapy has long been used to treat infantile hemangiomas, which has led to severe sequelae in adulthood. This article shares our experience in reconstructing the sequelae of radiation therapy for facial hemangioma using free anterolateral thigh (ALT) flap. Materials and methods: Six patients underwent facial lesion reconstruction using different ALT flaps, including volume augmentation, fascial, and thinning flaps. Results: The largest flap used was 20 × 8 cm Conclusion: The ALT flap has several advantages, including flexibility in use, diversity in flap components, and minimal impact on the donor site, making it increasingly popular and effective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.